Evidence map›Paper›PMID 39097525›Full record

ArticleBrain pathology (Zurich, Switzerland)2025

Microtubule-associated NAV3 regulates invasive phenotypes in glioblastoma cells.

Aneta Škarková, Markéta Pelantová, Ondřej Tolde, Anna Legátová, Rosana Mateu, Petr Bušek, Elena Garcia-Borja, Aleksi Šedo, Sandrine Etienne-Manneville, Daniel Rösel and 1 more

Abstract read
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Aneta ŠkarkováLaboratory of Cancer Cell Invasion, Department of Cell Biology, BIOCEV, Faculty of Science, Charles University, Vestec, Czech Republic.ORCID https://orcid.org/0000-0002-9255-8268
Markéta PelantováLaboratory of Cancer Cell Invasion, Department of Cell Biology, BIOCEV, Faculty of Science, Charles University, Vestec, Czech Republic.ORCID https://orcid.org/0009-0004-6994-5368
Ondřej ToldeLaboratory of Cancer Cell Invasion, Department of Cell Biology, BIOCEV, Faculty of Science, Charles University, Vestec, Czech Republic.ORCID https://orcid.org/0000-0002-3096-7381
Anna LegátováLaboratory of Cancer Cell Invasion, Department of Cell Biology, BIOCEV, Faculty of Science, Charles University, Vestec, Czech Republic.
Rosana MateuLaboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID https://orcid.org/0000-0001-6532-9219
Petr BušekLaboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID https://orcid.org/0000-0003-2158-4837
Elena Garcia-BorjaLaboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID https://orcid.org/0000-0002-5736-6797
Aleksi ŠedoLaboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID https://orcid.org/0000-0002-3247-5436
Sandrine Etienne-MannevilleCell Polarity, Migration and Cancer Unit, Université Paris Cité, UMR3691 CNRS, Institut Pasteur, Paris, France.ORCID https://orcid.org/0000-0001-6651-3675
Daniel RöselLaboratory of Cancer Cell Invasion, Department of Cell Biology, BIOCEV, Faculty of Science, Charles University, Vestec, Czech Republic.ORCID https://orcid.org/0000-0001-7221-8672
Jan BrábekLaboratory of Cancer Cell Invasion, Department of Cell Biology, BIOCEV, Faculty of Science, Charles University, Vestec, Czech Republic.ORCID https://orcid.org/0000-0001-7754-7299

Funding

Grantová Agentura, Univerzita Karlova 922120Ministerstvo Školství, Mládeže a Tělovýchovy Center for Tumor Ecology - Research of the CancerMinisterstvo Školství, Mládeže a Tělovýchovy Czech-BioImaging LM2023050Ministerstvo Školství, Mládeže a Tělovýchovy EATRIS-CZ LM2015064Ministerstvo Školství, Mládeže a Tělovýchovy National institute for cancer research LX22NPO5102Ministerstvo Zdravotnictví Ceské Republiky NV19-03-00501
6 · The paper itself

Abstract

Glioblastomas are aggressive brain tumors for which effective therapy is still lacking, resulting in dismal survival rates. These tumors display significant phenotypic plasticity, harboring diverse cell populations ranging from tumor core cells to dispersed, highly invasive cells. Neuron navigator 3 (NAV3), a microtubule-associated protein affecting microtubule growth and dynamics, is downregulated in various cancers, including glioblastoma, and has thus been considered a tumor suppressor. In this study, we challenge this designation and unveil distinct expression patterns of NAV3 across different invasion phenotypes. Using glioblastoma cell lines and patient-derived glioma stem-like cell cultures, we disclose an upregulation of NAV3 in invading glioblastoma cells, contrasting with its lower expression in cells residing in tumor spheroid cores. Furthermore, we establish an association between low and high NAV3 expression and the amoeboid and mesenchymal invasive phenotype, respectively, and demonstrate that overexpression of NAV3 directly stimulates glioblastoma invasive behavior in both 2D and 3D environments. Consistently, we observed increased NAV3 expression in cells migrating along blood vessels in mouse xenografts. Overall, our results shed light on the role of NAV3 in glioblastoma invasion, providing insights into this lethal aspect of glioblastoma behavior.

Indexed as

Brain NeoplasmsGlioblastomaNeoplasm InvasivenessPhenotypeAnimalsCell Line, TumorCell MovementHumansMembrane ProteinsMiceMicrotubulesNerve Tissue ProteinsMembrane ProteinsNAV3 protein, humanNerve Tissue ProteinsamoeboidglioblastomainvasionmesenchymalNAV3

Identifiers

PMID39097525
PMCPMC11669409

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.